June 12, 2017 - By Louis Casey
Idt Corp’s Chairman of the Board, Howard Jonas, acquired 1.00 million shares of stock in the company . The shares average cost was $14.9, for aggregate deal sum of $14.93 million USD. Published June 12, 2017, you can learn more about the investment by opening the following public 4F filing here. The probability of this acquisition staying unseen is extremely low due to its size, with the Chairman of the Board right now possessing 2.75 million shares – that is 11.37% of the market cap of the company.
Genomic Health, Inc. is a healthcare firm that provides genomic diagnostic tests to personalize cancer treatment. The company has market cap of $1.07 billion. The Firm develops and commercializes genomic clinical laboratory services. It currently has negative earnings. The Company’s Oncotype IQ Genomic Intelligence Platform is consisted of its flagship line of Oncotype DX gene expression tests, as well as its Oncotype SEQ Liquid Select test.
About 219,891 shares traded. IDT Corporation (NYSE:IDT) has risen 41.75% since June 12, 2016 and is uptrending. It has outperformed by 25.05% the S&P500.
Investors sentiment increased to 1.45 in Q4 2016. Its up 0.09, from 1.36 in 2016Q3. It is positive, as 14 investors sold IDT Corporation shares while 28 reduced holdings. 23 funds opened positions while 38 raised stakes. 12.59 million shares or 0.48% less from 12.65 million shares in 2016Q3 were reported. Chicago Equity Prns Limited Liability Company holds 0.11% or 214,415 shares. Hancock has invested 0.04% in IDT Corporation (NYSE:IDT). Swiss Comml Bank reported 0% stake. California Pub Employees Retirement has invested 0% of its portfolio in IDT Corporation (NYSE:IDT). 1.08 million are owned by Dimensional Fund Lp. Manufacturers Life Ins Com The has invested 0% of its portfolio in IDT Corporation (NYSE:IDT). Peak6 Investments Lp invested in 0% or 4,908 shares. Bowling Port Mngmt Ltd Limited Liability Company stated it has 32,148 shares. Northern Tru Corporation invested in 249,389 shares. State Common Retirement Fund owns 27,225 shares. Invesco Limited reported 0% stake. Zurcher Kantonalbank (Zurich Cantonalbank) holds 3 shares or 0% of its portfolio. Prudential Financial stated it has 24,064 shares. 1.80M are held by Vanguard. 21,329 were reported by Deutsche Bankshares Ag.
Since December 16, 2016, it had 1 insider purchase, and 4 insider sales for $9.69 million activity. PEREIRA BILL sold 10,222 shares worth $189,579. Another trade for 1,200 shares valued at $15,765 was sold by COSENTINO ERIC F. The insider MASON JOYCE J sold 3,000 shares worth $57,950. FISCHER MARCELO had sold 2,200 shares worth $44,455. Another trade for 728,332 shares valued at $10.00 million was made by JONAS HOWARD S on Tuesday, April 11.
IDT Corporation is a holding company with activities primarily in the telecommunications and payment industries. The company has market cap of $367.95 million. The Company’s divisions include Telecom Platform Services, Consumer Phone Services and All Other. It has a 11.89 P/E ratio. The Company’s Telecom Platform Services segment provides retail telecommunications and payment offerings, as well as wholesale international long distance traffic termination.
About 47,676 shares traded. Genomic Health, Inc. (GHDX) has risen 23.46% since June 12, 2016 and is uptrending. It has outperformed by 6.76% the S&P500.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.